Human Nlgn1/NL1 ORF/cDNA clone-Lentivirus plasmid (NM_014932.3)

Cat. No.: pGMLP001975
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human Nlgn1/NL1 Lentiviral expression plasmid for Nlgn1 lentivirus packaging, Nlgn1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to NLGN1/Nlgn1/NL1 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $1140.48
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP001975
Gene Name Nlgn1
Accession Number NM_014932.3
Gene ID 22871
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 2472 bp
Gene Alias NL1
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCACTGCCCAGATGCACGTGGCCAAATTATGTTTGGAGAGCAGTGATGGCATGCTTGGTACACCGGGGATTGGGTGCCCCATTGACTCTCTGTATGTTGGGATGTTTGCTTCAGGCTGGCCATGTGCTATCACAAAAATTGGATGATGTGGACCCACTGGTGGCTACCAACTTTGGAAAGATAAGAGGGATTAAGAAGGAACTCAATAATGAAATTTTGGGGCCTGTTATTCAATTTCTTGGGGTTCCATATGCAGCCCCACCAACAGGGGAACGTCGTTTTCAGCCTCCAGAACCACCATCTCCCTGGTCAGATATCAGAAATGCCACTCAATTTGCTCCTGTGTGTCCCCAGAATATCATTGATGGCAGATTGCCAGAAGTCATGCTTCCTGTGTGGTTTACTAATAACTTGGATGTGGTTTCATCATATGTGCAAGACCAGAGCGAAGACTGCCTATATTTAAATATATATGTCCCGACTGAGGATGATATTCGGGACAGTGGGGGTCCCAAACCAGTGATGGTGTATATCCATGGTGGCTCATATATGGAAGGTACTGGAAATTTATATGATGGAAGTGTCTTGGCAAGTTATGGCAATGTGATCGTCATCACAGTCAACTATCGACTTGGAGTACTCGGTTTCTTGAGTACAGGCGATCAGGCTGCAAAGGGGAACTATGGACTCCTTGATCTCATACAAGCTTTAAGATGGACTAGTGAAAACATTGGATTCTTTGGTGGTGACCCCTTAAGAATCACTGTTTTTGGATCTGGTGCTGGGGGTTCATGTGTCAACCTGCTGACTTTATCCCATTATTCTGAAGGTAACCGTTGGAGCAATTCAACCAAAGGACTTTTTCAACGAGCAATAGCTCAAAGTGGAACAGCCCTTTCCAGCTGGGCTGTTAGTTTTCAACCTGCAAAATATGCTAGAATGTTGGCCACAAAAGTTGGTTGCAATGTTTCAGATACAGTAGAGTTAGTGGAATGCCTACAGAAGAAGCCTTACAAAGAACTTGTTGACCAAGATATTCAACCAGCTCGATACCACATAGCCTTTGGACCTGTGATTGATGGTGATGTAATACCAGACGACCCCCAGATATTGATGGAGCAAGGAGAGTTTCTCAACTATGATATAATGTTAGGAGTGAACCAAGGGGAAGGGTTAAAATTTGTTGAAAATATAGTAGATAGCGATGATGGTATATCAGCTAGTGATTTTGACTTTGCTGTTTCAAATTTTGTTGATAATTTATATGGATATCCTGAAGGCAAAGATGTTTTGAGAGAAACCATTAAGTTCATGTATACTGACTGGGCTGACCGTCATAACCCTGAAACCAGAAGAAAGACATTACTGGCTTTGTTTACGGACCATCAGTGGGTGGCACCAGCTGTAGCCACAGCGGATCTTCACTCAAACTTTGGTTCACCTACGTACTTCTATGCCTTTTACCATCATTGCCAAACAGATCAGGTTCCAGCTTGGGCTGATGCAGCCCACGGAGACGAGGTTCCCTATGTACTGGGAATCCCCATGATTGGCCCTACAGAGTTATTTCCTTGCAATTTCTCCAAAAATGATGTGATGCTGAGTGCAGTTGTAATGACATACTGGACAAATTTTGCTAAAACTGGTGACCCAAATCAACCAGTCCCTCAAGACACGAAATTCATTCATACCAAACCCAACCGTTTTGAAGAAGTAGCATGGACCAGATATTCCCAGAAAGACCAACTTTATCTCCATATTGGATTAAAACCAAGAGTTAAAGAACATTACAGAGCCAATAAGGTGAACCTCTGGTTGGAGTTGGTACCTCATCTGCATAATCTCAATGACATTTCTCAGTATACCTCTACAACAACTAAAGTGCCATCAACTGACATCACTTTCAGACCTACGAGAAAAAATTCTGTACCTGTCACGTCAGCCTTTCCCACTGCCAAGCAGGATGATCCCAAACAACAACCAAGTCCATTTTCAGTGGATCAAAGGGACTACTCAACAGAGCTGAGTGTCACTATTGCAGTTGGAGCATCACTGCTGTTTCTGAACATCTTGGCCTTTGCAGCCCTGTACTACAAAAAGGATAAGAGGAGACATGATGTTCACAGGAGATGCAGCCCTCAGCGCACTACTACCAATGATCTAACCCATGCACAAGAAGAGGAAATCATGTCCCTCCAAATGAAGCACACTGATTTGGATCATGAATGTGAGTCCATTCATCCACATGAGGTGGTTCTTCGGACCGCCTGTCCCCCAGATTACACACTAGCTATGAGGAGGTCACCTGATGATGTTCCCTTAATGACACCCAACACCATTACAATGATTCCCAACACTATACCAGGGATTCAGCCCTTACACACATTCAATACATTTACTGGAGGACAGAACAATACTCTGCCCCATCCCCATCCCCACCCCCATTCACATTCAACAACCAGGGTATAG
ORF Protein Sequence MALPRCTWPNYVWRAVMACLVHRGLGAPLTLCMLGCLLQAGHVLSQKLDDVDPLVATNFGKIRGIKKELNNEILGPVIQFLGVPYAAPPTGERRFQPPEPPSPWSDIRNATQFAPVCPQNIIDGRLPEVMLPVWFTNNLDVVSSYVQDQSEDCLYLNIYVPTEDDIRDSGGPKPVMVYIHGGSYMEGTGNLYDGSVLASYGNVIVITVNYRLGVLGFLSTGDQAAKGNYGLLDLIQALRWTSENIGFFGGDPLRITVFGSGAGGSCVNLLTLSHYSEGNRWSNSTKGLFQRAIAQSGTALSSWAVSFQPAKYARMLATKVGCNVSDTVELVECLQKKPYKELVDQDIQPARYHIAFGPVIDGDVIPDDPQILMEQGEFLNYDIMLGVNQGEGLKFVENIVDSDDGISASDFDFAVSNFVDNLYGYPEGKDVLRETIKFMYTDWADRHNPETRRKTLLALFTDHQWVAPAVATADLHSNFGSPTYFYAFYHHCQTDQVPAWADAAHGDEVPYVLGIPMIGPTELFPCNFSKNDVMLSAVVMTYWTNFAKTGDPNQPVPQDTKFIHTKPNRFEEVAWTRYSQKDQLYLHIGLKPRVKEHYRANKVNLWLELVPHLHNLNDISQYTSTTTKVPSTDITFRPTRKNSVPVTSAFPTAKQDDPKQQPSPFSVDQRDYSTELSVTIAVGASLLFLNILAFAALYYKKDKRRHDVHRRCSPQRTTTNDLTHAQEEEIMSLQMKHTDLDHECESIHPHEVVLRTACPPDYTLAMRRSPDDVPLMTPNTITMIPNTIPGIQPLHTFNTFTGGQNNTLPHPHPHPHSHSTTRV

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP0886-Ab Anti-NLGN1/ NL1 monoclonal antibody
    Target Antigen GM-Tg-g-MP0886-Ag NLGN1 VLP (virus-like particle)
    ORF Viral Vector pGMLP001975 Human Nlgn1 Lentivirus plasmid
    ORF Viral Vector vGMLP001975 Human Nlgn1 Lentivirus particle


    Target information

    Target ID GM-MP0886
    Target Name NLGN1
    Gene ID 22871, 192167, 693541, 116647, 101081489, 488173, 530042, 100058013
    Gene Symbol and Synonyms 6330415N05Rik,mKIAA1070,NL1,Nlg1,NLGN1
    Uniprot Accession Q8N2Q7
    Uniprot Entry Name NLGN1_HUMAN
    Protein Sub-location Transmembrane Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000169760
    Target Classification Not Available

    This gene encodes a member of a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. [provided by RefSeq, Jul 2008]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.